DEDICATED TO EXCELLENCE IN CUSTOM SYNTHESIS

Alchem Laboratories has manufactured APIs and drug products for over 80 clinical trials in the last 10 years, including 22 active clinical studies in clinicaltrials.gov:

  • NCT03931928 Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients

  • NCT03317405 Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery

  • NCT01273168 Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

  • NCT01327781 Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer

  • NCT02311933 Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

  • NCT03327064 A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer

  • NCT02876640 Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

  • NCT02423057 Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors

  • NCT03366116 5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT04494113 Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy

  • NCT04234568 Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors

  • NCT02595879 Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

  • NCT02466971 Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

  • NCT02910011 Topical NanoDOX® for Atopic Dermatitis

  • NCT02535325 Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer

  • NCT02535312 Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin

  • NCT01851369 TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas

  • NCT03030417 Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas

  • NCT04724720 Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19